It is worth noting that malignant CLL cells release TNFα [35], and the levels of plasma TNFα, which were higher in CLL patients than in healthy controls, correlated with disease stage, CD38 expression and chromosomal abnormalities (17p and 11q deletion) [36]. This evidence concerns the gene TNF and B-cell chronic lymphocytic leukemia.